Related Experiment Video
Updated: Dec 30, 2025
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Class C1 decoy oligodeoxynucleotide inhibits profibrotic genes expression in rat hepatic stellate cells
Chun Rao1, Yi-Ran Ni2, Yan-Min Zhao2
1Department of Pathology, The People's Hospital of China Three Gorges University and the First People's Hospital of Yichang, Yichang, Hubei 443000, P.R. China.
Abstract:
The aim of the present study was to investigate whether class C1 decoy oligodeoxynucleotides (ODNs) can inhibit the expression of pro‑fibrotic genes associated with rat hepatic stellate cell (HSC) activation and hepatic fibrosis. Luciferase reporter assays were performed to test the promoter activities of transforming growth factor (TGF)‑β and its downstream target genes following transfection of decoy ODNs and plasmids into HSC‑T6 cells, and western blot assays were performed to measure the protein expression of those genes following decoy ODN transfection. Class C1 decoy ODNs were confirmed to inhibit the promoter activity of TGF‑β and its downstream target genes, such as type 1 collagen (COLI)α1, tissue inhibitor of metalloproteinases (TIMP)1 and α‑smooth muscle actin by Gaussia luciferase reporter assay, and to further downregulate the expression of TGF‑β, SMAD3, COLIα1 and TIMP1 by western blotting in activated HSC‑T6 cells. In conclusion, class C1 decoy ODNs inhibited pro‑fibrotic gene expression in rat HSCS by downregulating TGF‑β signaling.
Insights
Class C1 decoy oligodeoxynucleotides (ODNs) effectively inhibit pro-fibrotic gene expression in rat hepatic stellate cells (HSCs). This study demonstrates their potential to downregulate transforming growth factor-beta (TGF-β) signaling, offering a novel therapeutic approach for hepatic fibrosis.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Hepatic fibrosis is characterized by excessive extracellular matrix deposition, driven by activated hepatic stellate cells (HSCs).
- Transforming growth factor-beta (TGF-β) signaling is a key pathway promoting HSC activation and fibrogenesis.
- Targeting pro-fibrotic gene expression is a crucial strategy for treating liver fibrosis.
Purpose of the Study:
- To investigate the inhibitory effect of class C1 decoy oligodeoxynucleotides (ODNs) on pro-fibrotic gene expression in activated rat HSCs.
- To determine if class C1 decoy ODNs can modulate the TGF-β signaling pathway in HSCs.
Main Methods:
- Luciferase reporter assays were used to assess the promoter activity of TGF-β and its downstream genes (COLIα1, TIMP1, α-SMA) in HSC-T6 cells transfected with decoy ODNs.
- Western blot assays were performed to measure the protein levels of TGF-β, SMAD3, COLIα1, and TIMP1 in activated HSC-T6 cells following decoy ODN treatment.
Main Results:
- Class C1 decoy ODNs significantly inhibited the promoter activity of TGF-β and its downstream target genes, including type 1 collagen (COLIα1), tissue inhibitor of metalloproteinases (TIMP1), and α-smooth muscle actin.
- Western blot analysis confirmed that decoy ODNs downregulated the protein expression of TGF-β, SMAD3, COLIα1, and TIMP1 in activated HSC-T6 cells.
Conclusions:
- Class C1 decoy ODNs effectively suppress pro-fibrotic gene expression in rat HSCs.
- The mechanism involves the downregulation of the TGF-β signaling pathway.
- These findings suggest that class C1 decoy ODNs hold therapeutic potential for managing hepatic fibrosis.
